tBuO-C20-γ-Glu(AEEA)-OtBu
CAS Number: 2645421-68-5
Category:
Side Chain
Synonyms: (S)-13-(tert-butoxycarbonyl)-10,15-dihydroxy-36,36-dimethyl-34-oxo-3,6,35-trioxa-9,14-diazaheptatriaconta-9,14-dienoic acid;
34-(1,1-Dimethylethyl) (13S)-13-[(1,1-dimethylethoxy)carbonyl]-10,15-dioxo-3,6-dioxa-9,14-diazatetratriacontanedioate
34-(1,1-Dimethylethyl) (13S)-13-[(1,1-dimethylethoxy)carbonyl]-10,15-dioxo-3,6-dioxa-9,14-diazatetratriacontanedioate
GMP-compliant
Commercial supply&le stock
Various Packaging Available
Factory documentation support
Product Specifications
| CAS Number | 2645421-68-5 |
|---|---|
| Molecular Formula | C39H72N2O10 |
| Molecular Weight | 729.00 |
| Purity | 98% |
| Appearance | White to off-white solid |
| Storage Conditions | -20℃ |
| Package | From 100g/bottle to 25kg/drum |
Product Overview
tBuO-C20-γ-Glu(AEEA)-OtBu
(S)-13-(tert-butoxycarbonyl)-10,15-dihydroxy-36,36-dimethyl-34-oxo-3,6,35-trioxa-9,14-diazaheptatriaconta-9,14-dienoic acid
CAS: 2645421-68-5
Applications
Peptide Side Chains: Used as a key intermediate in the synthesis of lipophilic side chains for long-acting peptide drugs (such as Retatrutide, Tirzepatide, and other GLP-1/GIP/Gcg receptor agonists). It incorporates a long-chain fatty acid derivative (C20 diacid), a gamma-glutamic acid spacer, and a mini-PEG (AEEA) linker to extend peptide plasma half-life via albumin binding.
Quality Assurance
Can be tested according to the customer’s method of analysis.
Certificate of Analysis (COA) and Material Safety Data Sheets (MSDS) provided upon request.
